Skip to Content
CancersCancers
  • Review
  • Open Access

28 February 2026

37 Pages

Metal Ion-Mediated Regulation of Cell Fate: A Novel Strategy for Synergy with Radiotherapy and Immunotherapy

,
,
,
,
,
and
1
Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, The Third Affiliated Hospital of Soochow University, Soochow University, Suzhou 215123, China
2
Department of Thoracic Surgery, Suzhou Municipal Hospital Institution, Suzhou 215000, China
*
Authors to whom correspondence should be addressed.

Simple Summary

Radiotherapy and immunotherapy are key cancer treatments, yet both face limitations. Metal ions, beyond their traditional roles, are now recognized as important regulators of cell death and immune responses. This review explains how metal ions influence cell fate and anti-tumor immunity, and explores their potential to enhance radiotherapy by boosting immune effects and overcoming resistance. By connecting these mechanisms, our work provides a clear framework for developing new combined therapies, offering valuable insights for researchers and clinicians in oncology, immunology, and related fields.

Abstract

Metal ions are indispensable for living organisms, participating in essential physiological processes. However, their dysregulated accumulation can trigger cell death and metal overload. The recent discovery of novel regulated cell death modalities, such as cuproptosis and ferroptosis, has significantly advanced the understanding of metal ions in cell fate and immune regulation. This review systematically elucidates the molecular mechanisms underlying metal ion-induced cell death, encompassing oxidative stress, mitochondrial dysfunction, DNA damage, and epigenetic modifications. It further classifies and discusses the hallmarks of various programmed and non-programmed cell death pathways, emphasizing the pivotal role of metal ions in anti-tumor immunity. Moreover, we highlight an emerging therapeutic approach-metal ion-based immunotherapy, which represents a compelling strategy when combined with radiotherapy to amplify therapeutic outcomes. This combined modality holds significant promise for overcoming radiotherapy resistance and expanding its abscopal effects. Finally, current challenges and future research directions in the field of metal immunity are outlined to facilitate the translational application of metal ions in disease therapy and immune modulation.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.